| Literature DB >> 35537783 |
Svenja B Frenzel1, S Alexander Haslam2, Nina M Junker3,4, Aidos Bolatov5, Valerie A Erkens6, Jan A Häusser6, Ronit Kark7,8, Ines Meyer9, Andreas Mojzisch10, Lucas Monzani11, Stephen D Reicher12, Adil Samekin13, Sebastian C Schuh14, Niklas K Steffens2, Liliya Sultanova15, Dina Van Dijk16, Llewellyn E van Zyl3,17,18,19, Rolf van Dick3.
Abstract
OBJECTIVES: To investigate whether citizens' adherence to health-protective non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic is predicted by identity leadership, wherein leaders are perceived to create a sense of shared national identity.Entities:
Keywords: COVID-19; Health policy; Public health
Mesh:
Year: 2022 PMID: 35537783 PMCID: PMC9091491 DOI: 10.1136/bmjopen-2021-054980
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Dropouts and exclusions in the four subsamples at Time 1 and Time 2.
Figure 2Mediation model. NPI, non-pharmaceutical intervention.
Demographic variables and statistical comparisons across China, Germany, Israel and USA
| China | Germany | Israel | USA | P value* | |
| Age | |||||
| M (SD) | 30.38 (5.97) | 34.94 (13.65) | 40.76 (11.41) | 44.51 (10.66) | <0.001 |
| Gender n (%) | |||||
| Female | 365 (66.6) | 142 (78.0) | 101 (51.0) | 63 (58.3) | <0.001 |
| Male | 181 (33.0) | 40 (22.0) | 97 (49.0) | 45 (41.7) | |
| Diverse† | 2 (0.4) | 0 | 0 | 0 | |
| Job status n (%) | |||||
| Employed | 448 (81.8) | 131 (72.0) | 161 (81.3) | 90 (83.3) | 0.025 |
| Unemployed | 100 (18.2) | 51 (28.0) | 37 (18.7) | 18 (16.7) | |
| Parenthood n (%) | |||||
| Yes | 238 (43.4) | 63 (34.6) | 134 (67.7) | 52 (48.1) | <0.001 |
| No | 310 (56.6) | 119 (65.4) | 64 (32.3) | 56 (51.9) |
*P values were calculated with a univariate analysis of variance or Pearson’s χ2 test.
†Two people were excluded from Pearson’s χ2 analysis.
Means (M), standard deviations (SD), skewness (SK) and kurtosis-values (RKU), internal consistencies (α) and Pearson correlations among the study variables in the Chinese, German, Israeli and US subsamples
|
|
|
|
|
|
|
|
|
| 1. Identity leadership† | 6.43 | 0.77 | −2.15 | 6.97 | 0.91 | ||
| 2. Perceived shared national identification‡ | 4.30 | 0.51 | −0.53 | −0.13 | 0.77 | 0.31*** | |
| 3. Adherence to health-protective NPIs§ | 4.16 | 0.41 | −0.36 | −0.48 | 0.74 | 0.14** | 0.37*** |
|
| |||||||
| 1. Identity leadership | 5.31 | 1.20 | −0.93 | 0.93 | 0.88 | ||
| 2. Perceived shared national identification | 3.87 | 0.62 | −0.36 | 0.12 | 0.80 | 0.41*** | |
| 3. Adherence to health-protective NPIs | 3.87 | 0.57 | −0.54 | 0.55 | 0.71 | 0.33*** | 0.31*** |
|
| |||||||
| 1. Identity leadership | 3.53 | 1.89 | 0.28 | −1.11 | 0.93 | ||
| 2. Perceived shared national identification | 3.32 | 0.78 | −0.69 | 0.85 | 0.80 | 0.41*** | |
| 3. Adherence to health-protective NPIs | 3.66 | 0.60 | −0.56 | 1.25 | 0.81 | 0.19** | 0.20** |
|
| |||||||
| 1. Identity leadership | 2.44 | 1.96 | 0.94 | −0.74 | 0.97 | ||
| 2. Perceived shared national identification | 3.55 | 0.88 | −0.92 | 0.57 | 0.92 | 0.41*** | |
| 3. Adherence to health-protective NPIs | 4.19 | 0.65 | −0.82 | 0.57 | 0.84 | −0.19 | 0.17 |
*p<0.05, **p<0.01, ***p<0.001.
†Mean scores on the Identity Leadership Inventory Short-Form range from 1 to 7, with higher scores indicating a stronger perception of the national leader’s engagement in identity leadership. Identity leadership was assessed at Time 1.
‡Mean scores on the PSNI Scale range from 1 to 5, with higher scores indicating more PSNI within the respective country. PSNI was assessed at Time 2.
§Mean scores on the Adherence to Health-Protective NPIs Scale range from 1 to 5, with higher scores indicating a stronger adherence to the NPIs. Adherence to NPIs was assessed at Time 2.
NPI, non-pharmaceutical intervention.
Results of hypothesis testing (unconstrained mediation model)
| Chinese subsample | German subsample | Israeli subsample | US subsample | |||||
| PSNI | Adherence to health-protective NPIs | PSNI | Adherence to health-protective NPIs | PSNI | Adherence to health-protective NPIs | PSNI | Adherence to health-protective NPIs | |
| b (SE)† | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | |
|
| −0.01 (0.00) | 0.01 (0.00)*** | – | – | – | – | – | – |
|
| – | – | – | – | – | – | 0.17 (0.15) | 0.42 (0.11)*** |
|
| – | – | −0.05 (0.11) | −0.18 (0.09)* | – | – | – | – |
|
| 0.21 (0.03)*** | 0.02 (0.02) | 0.21 (0.05)*** | 0.11 (0.04)** | 0.17 (0.03)*** | 0.04 (0.03) | 0.18 (0.03)*** | −0.10 (0.03)** |
|
| 0.29 (0.03)*** | 0.20 (0.08)* | 0.12 (0.08) | 0.19 (0.08)* | ||||
*p<0.05, **p<0.01, ***p<0.001.
†The result is an unstandardised regression coefficient and SE.
‡1 = yes, 0 = no.
§1 = women, 2 = men, 3 = diverse
IL, identity leadership; NPI, non-pharmaceutical intervention; PSNI, perceived shared national identification.